Filing Details

Accession Number:
0001438133-20-000157
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-11-12 16:49:47
Reporting Period:
2020-11-10
Accepted Time:
2020-11-12 16:49:47
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1438133 Tandem Diabetes Care Inc TNDM () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1238913 D Kim Blickenstaff C/O Tandem Diabetes Care, Inc.
11075 Roselle Street
San Diego CA 92121
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-11-10 6,048 $11.06 891,390 No 4 M Indirect See Footnote
Common Stock Disposition 2020-11-10 25,000 $100.09 866,390 No 4 S Indirect See Footnote
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Indirect See Footnote
No 4 S Indirect See Footnote
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2020-11-10 6,048 $0.00 6,048 $11.06
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 M Direct
Footnotes
  1. Represents shares of common stock received upon exercise of a stock option award.
  2. The securities are held by the Kim Blickenstaff Revocable Trust dated April 15, 2010.
  3. Shares sold are from long shares held by the Kim Blickenstaff Revocable Trust, dated April 15, 2010.
  4. The price reported reflects the weighted average price per share of multiple transactions with prices per share ranging between $100.00 to $100.82. The Reporting Person undertakes to provide the Securities and Exchange Commission (the "SEC"), the issuer, and any security holder full information regarding the number of shares and the prices at which the shares were sold.
  5. The option vested as to thirty-three percent (33.33%) of the underlying shares on 05/23/2013, 01/23/2014 and 01/23/2015.
  6. The expiration date for these options is 10 years from the date of grant.